Distinct roles of c-Abl and Atm in oxidative stress response are mediated by protein kinase C δ

Genes and Development

Volumn 18, Issue 15, 2004, Pages 1824-1837

  Li, Baojie ^a   Wang, Xueying ^a   Rasheed, Naslin ^a   Hu, Yuanyu ^a   Boast, Sharon ^b,e   Ishii, Tetsuro ^c   Nakayama, Keiko ^d   Nakayama, Keiichi I ^d   Golf, Stephen P ^b  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b College of Physicians and Surgeons ^*  (United States)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Atm; c Abl; Nrf2; Osteoblasts; Oxidative stress; Prx I

Indexed keywords

ABELSON KINASE; ARSENIC ACID; ATM PROTEIN; LEUCINE ZIPPER PROTEIN; PEROXIREDOXIN; PROTEIN KINASE C GAMMA; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; DNA RESPONSIVE ELEMENT; GENE OVEREXPRESSION; MOUSE; NONHUMAN; NORTHERN BLOTTING; OSTEOBLAST; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; ARSENATES; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; ENZYME ACTIVATION; HERBICIDES; HOMOZYGOTE; LEUCINE ZIPPERS; MICE; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; OSTEOBLASTS; OXIDATIVE STRESS; PEROXIDASES; PHENOTYPE; PHOSPHOLIPASES A; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-ABL; REACTIVE OXYGEN SPECIES; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUBCELLULAR FRACTIONS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 3543084994     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1223504     Document Type: Article

References (50)

1. Aono, J., Yanagawa, T., Itoh, K., Li, B., Yoshida, H., Kumagai, Y., Yamamoto, M., and Ishii, T. 2003. Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts. Biochem. Biophys. Res. Commun. 305: 271-277.
2. Barlow, C., Dennery, P.A., Shigenaga, M.K., Smith, M.A., Morrow, J.D., Roberts, L.J., Wynshaw-Boris, A., and Levine, R.L. 1999. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl. Acad. Sci. 96: 9915-9919.
3. Baskaran, R., Wood, L.D., Whitaker, L.L., Canman, C.E., Morgan, S.E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M.B., et al. 1997. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387: 516-519.
4. Beckman, K.B. and Ames, B.N. 1998. The free radical theory of aging matures. Physiol. Rev. 78: 547-581.
5. Blake, R.A., Garcia-Paramio, P., Parker, P.J., and Courtneidge, S.A. 1999. Src promotes PKCdelta degradation. Cell Growth Differ. 10: 231-241.
6. Chan, K. and Kan, Y.W. 1999. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc. Natl. Acad. Sci. 96: 12731-12736.
7. Chan, K., Han, X.D., and Kan, Y.W. 2001. An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen. Proc. Natl. Acad. Sci. 98: 4611-4616.
8. Chang, T.S., Jeong, W., Choi, S.Y., Yu, S., Kang, S.W., and Rhee, S.G. 2002. Regulation of peroxiredoxin I activity by Cdc2-mediated phosphorylation. J. Biol. Chem. 277: 25370-25376.
9. Cong, F., Spencer, S., Cote, J.F., Wu, Y., Tremblay, M.L., Lasky, L.A., and Goff, S.P. 2000. Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation. Mol. Cell 6: 1413-1423.
10. Dorsch, M. and Goff, S.P. 1996. Increased sensitivity to apoptotic stimuli in c-abl-deficient progenitor B-cell lines. Proc. Natl. Acad. Sci. 93: 13131-13136.
11. Goga, A., Liu, X., Hambuch, T.M., Senechal, K., Major, E., Berk, A.J., Witte, O.N., and Sawyers, C.L. 1995. p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase. Oncogene 11: 791-799.
12. Gong, J.G., Costanzo, A., Yang, H.Q., Melino, G., Kaelin Jr., W.G., Levrero, M., and Wang, J.Y. 1999. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399: 806-809.
13. Gopalakrishna, R. and Jaken, S. 2000. Protein kinase C signaling and oxidative stress. Free Radic. Biol. Med. 28: 1349-1361.
14. Gschwendt, M. 1999. Protein kinase C δ. Eur. J. Biochem. 259: 555-564.
15. Gudkov, A.V. and Komarova, E.A. 2003. The role of p53 in determining sensitivity to radiotherapy. Nat. Rev. Cancer 3: 117-129.
16. Halliwell, B. and Gutteridge, J.M. 1990. Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol. 186: 1-85.
17. Herzog, K.H., Chong, M.J., Kapsetaki, M., Morgan, J.I., and McKinnon, P.J. 1998. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 280: 1089-1091.
18. Huang, H.C., Nguyen, T., and Pickett, C.B. 2002. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 277: 42769-42774.
19. Ishii, T., Yamada, M., Sato, H., Matsue, M., Taketani, S., Nakayama, K., Sugita, Y., and Bannai, S. 1993. Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein. J. Biol. Chem. 268: 18633-18636.
20. Ishii, T., Kawane, T., Taketani, S., and Bannai, S. 1995. Inhibition of the thiol-specific antioxidant activity of rat liver MSP23 protein by hemin. Biochem. Biophys. Res. Commun. 216: 970-975.
21. Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S., and Yamamoto, M. 2000. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275: 16023-16029.
22. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., O'Connor, T., and Yamamoto, M. 2003. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 8: 379-391.
23. Kamsler, A., Daily, D., Hochman, A., Stern, N., Shiloh, Y., Rotman, G., and Barzilai, A. 2001. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res. 61: 1849-1854.
24. Key Jr., L.L., Wolf, W.C., Gundberg, C.M., and Ries, W.L. 1994. Superoxide and bone resorption. Bone 15: 431-436.
25. Khanna, K.K., Keating, K.E., Kozlov, S., Scott, S., Gatei, M., Hobson, K., Taya, Y., Gabrielli, B., Chan, D., Lees-Miller, S.P., et al. 1998. ATM associates with and phosphorylates p53: Mapping the region of interaction. Nat. Genet. 20: 398-400.
26. 2-treated cells and its activation by tyrosine kinase in vitro. Proc. Natl. Acad. Sci. 98: 6587-6592.
27. Leitges, M., Mayr, M., Braun, U., Mayr, U., Li, C., Pfister, G., Ghaffari-Tabrizi, N., Baier, G., Hu, Y., and Xu, Q. 2001. Exacerbated vein graft arteriosclerosis in protein kinase Cdelta-null mice. J. Clin. Invest. 108: 1505-1512.
28. Li, B., Boast, S., de los, S.K., Schieren, I., Quiroz, M., Teitelbaum, S.L., Tondravi, M.M., and Goff, S.P. 2000. Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nat. Genet. 24: 304-308.
29. Li, B., Ishii, T., Tan, C.P., Soh, J.W., and Goff, S.P. 2002. Pathways of induction of peroxiredoxin I expression in osteoblasts: Roles of p38 mitogen-activated protein kinase and protein kinase C. J. Biol. Chem. 277: 12418-12422.
30. McMahon, M., Itoh, K., Yamamoto, M., and Hayes, J.D. 2003. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J. Biol. Chem. 278: 21592-21600.
31. Miyamoto, A., Nakayama, K., Imaki, H., Hirose, S., Jiang, Y., Abe, M., Tsukiyama, T., Nagahama, H., Ohno, S., Hatakeyama, S., et al. 2002. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase C δ. Nature 416: 865-869.
32. Morita, S., Kojima, T., and Kitamura, T. 2000. Plat-E: An efficient and stable system for transient packaging of retroviruses. Gene Ther. 7: 1063-1066.
33. Nguyen, T., Sherratt, P.J., Huang, H.C., Yang, C.S., and Pickett, C.B. 2003. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J. Biol. Chem. 278: 4536-4541.
34. Prosperi, M.T., Ferbus, D., Rouillard, D., and Goubin, G. 1998. The pag gene product, a physiological inhibitor of c-abl tyrosine kinase, is overexpressed in cells entering S phase and by contact with agents inducing oxidative stress. FEBS Lett. 423: 39-44.
35. Ramos-Gomez, M., Kwak, M.K., Dolan, P.M., Itoh, K., Yamamoto, M., Talalay, P., and Kensler, T.W. 2001. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. 98: 3410-3415.
36. Rotman, G. and Shiloh, Y. 1997. Ataxia-telangiectasia: Is ATM a sensor of oxidative damage and stress? Bioessays 19: 911-917.
37. Sakurai, M., Oba, M., Matsumoto, K., Tokura, Y., Furukawa, F., and Takigawa, M. 2000. Acute infectious urticaria: Clinical and laboratory analysis in nineteen patients. J. Dermatol. 27: 87-93.
38. Shafman, T., Khanna, K.K., Kedar, P., Spring, K., Kozlov, S., Yen, T., Hobson, K., Gatei, M., Zhang, N., Watters, D., et al. 1997. Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387: 520-523.
39. Sharpless, N.E. and DePinho, R.A. 2002. p53: Good cop/bad cop. Cell 110: 9-12.
40. Shiloh, Y. 1997. Ataxia-telangiectasia and the Nijmegen breakage syndrome: Related disorders but genes apart. Annu. Rev. Genet. 31: 635-662.
41. Stewart, D., Killeen, E., Naquin, R., Alam, S., and Alam, J. 2003. Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium. J. Biol. Chem. 278: 2396-2402.
42. Sun, X., Majumder, P., Shioya, H., Wu, F., Kumar, S., Weichselbaum, R., Kharbanda, S., and Kufe, D. 2000a. Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species. J. Biol. Chem. 275: 17237-17240.
43. Sun, X., Wu, F., Datta, R., Kharbanda, S., and Kufe, D. 2000b. Interaction between protein kinase C δ and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J. Biol. Chem. 275: 7470-7473.
44. Takao, N., Mori, R., Kato, H., Shinohara, A., and Yamamoto, K. 2000. c-Abl tyrosine kinase is not essential for ataxia telangiectasia mutated functions in chromosomal maintenance. J. Biol. Chem. 275: 725-728.
45. Van Etten, R.A. 1999. Cycling, stressed-out and nervous: Cellular functions of c-Abl. Trends Cell Biol. 9: 179-186.
46. Wang, J.Y. 2000. Regulation of cell death by the Abl tyrosine kinase. Oncogene 19: 5643-5650.
47. Wen, S.T. and Van Etten, R.A. 1997. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes & Dev. 11: 2456-2467.
48. Westphal, C.H., Rowan, S., Schmaltz, C., Elson, A., Fisher, D.E., and Leder, P. 1997. atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat. Genet. 16: 397-401.
49. Wood, Z.A., Schroder, E., Robin, H.J., and Poole, L.B. 2003. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28: 32-40.
50. Xu, Y., Ashley, T., Brainerd, E.E., Bronson, R.T., Meyn, M.S., and Baltimore, D. 1996. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes & Dev. 10: 2411-2422.